DMAE (Dimethylaminoethanol, sometimes called Deanol) is an organic compound that is naturally produced in the human brain as well as being found in food sources like fish (anchovies, salmon, and sardines).
As a nootropic supplement, it is closely related to Choline but due to a slightly different chemical structure it crosses the blood-brain barrier much more easily.
Many individuals interested in boosting their brainpower will take DMAE instead of Choline Bitartrate because it provides a more noticeable increase in cognitive abilities. Nowadays, more people use Centrophenoxine which is an enhanced version of DMAE with similar effects but greater potency.
DMAE is purported to have benefits for memory, focus, mental processing, attentional control and executive function. How exactly does it work and what is the best way to use this supplement to achieve the purported benefits?



- Found to enhance mental concentration
- Supports memory by boosting acetylcholine
- Neuroprotective with anti-aging effects
DMAE Effects
Related Topics
DMAE and Choline are very similar except that DMAE only has 2 methyl molecules attached to its nitrogen molecule while Choline has 3. This means that DMAE readily crosses the blood-brain barrier while many forms of Choline have poor transportation across this barrier.
Once DMAE enters your brain cells, it is converted into Acetylcholine. This newly formed chemical is a powerful neurotransmitter that has a critical role in a number of different mental processes like memory formation and learning.
Acetylcholine is considered to be one of the most pivotal neurotransmitters for the formation of new connections between neurons and the plasticity of the brain.
As much as 90% of the general population is thought to be deficient in the nutrients needed to make Acetylcholine and this percentage may be even higher among critical population groups like elderly individuals. As such, taking Acetylcholine precursor supplements is often necessary to ensure optimal brain function.
DMAE is one of the best choices for boosting your levels of this neurotransmitter, which may help lead to enhanced memory, cognition, reasoning, focus, and learning skills. Centrophenoxine, which is synthesized from DMAE, is considered even better and has been studied as a treatment to repair brain damage as seen in Alzheimer’s patients and stroke survivors.
DMAE is also known to bind to phospholipids in the brain. In this capacity, a large amount of the supplement is actually incorporated into the nerve membranes present within the brain. It is also this type of action thought to be responsible for acting as an anti-oxidant along with helping to improve brain and neuronal health.
DMAE increases the fluidity and permeability of the nerve membranes, ensuring that they get necessary nutrients in and unwanted waste products out. Cell membrane fluidity declines as we age, but DMAE may be able to reverse or prevent this sign of aging from occurring.
DMAE Benefits
There are numerous benefits that have been associated with DMAE supplementation. This includes improved emotional states, greater energy levels, and alertness. This is perhaps due to the enhanced efficiency of nerve cells within the brain to communicate with one another.
Using DMAE has also been reported to cause sensations of calmness and a reduction in stress and anxiety levels. Successful studies found that DMAE actually had an anti-anxiety effect on students during exam times.
Many users also experience memory improvements when taking Deanol pills or powder. This is likely due to the increased levels of Acetylcholine which the supplement is known to produce.
This powerful neurotransmitter can increase the rate of memory formation in your brain, boost learning capacity and even lengthen attention span, focus, and concentration. There is evidence suggesting that this supplement may be helpful for people with cognitive impairments such as learning disabilities, age-related cognitive decline, or even attention-deficit disorder, however research is limited.
Another interesting and fairly unique use of DMAE is for inducing the state known as lucid dreaming. When lucid dreaming, you are aware that you are actually dreaming and can control the actions which happen within the dream itself.
This is noted for improving creativity, problem solving, associative thinking, and even mood. Many individuals engage in lucid dreaming for recreational purposes or purely for personal enjoyment. Others find it to be especially effective for training for athletic competitions or other tasks which require intense focus and concentration.
DMAE is also known to improve skin tone and firmness, in addition to offering a number of anti-aging benefits. DMAE is actually used in many different types of skin care products. It will help your skin to look younger and free of blemishes while reducing inflammation.
One of the ways this is thought to work is by slowing down the production of arachidonic acid, which is one of the main chemicals that leads to wrinkles and other signs of aging of the skin.
Research on DMAE is promising, but limited, and more studies are still needed. At this time, DMAE is available as a health supplement only, and the FDA has not approved DMAE as a drug to prevent or treat any conditions.
DMAE for ADHD Treatment
In the 1970s, DMAE was sold under the trade name Deaner by Riker Laboratories as a prescription pharmaceutical in Europe.
Deaner was initially investigated as a drug for the treatment of ADHD in children. It was found to improve behavioural conditions in children and to have benefits for hyperactivity. However, studies on its effects for ADHD treatment have yielded mixed results.
In 1975, one study examined the effects of this supplement on 74 children diagnosed with learning disabilities and hyperactivity. The group was treated for three months with either a placebo, 500 mg of DMAE, or 40 mg of the ADHD drug Ritalin (methylphenidate).
Children given either DMAE or Ritalin experienced improvements in tests of concentration and skills, while those given the placebo saw no improvements. This suggested that DMAE could be used as a safer alternative to treatment with stimulants like Ritalin.
In 1976, a double-blind placebo controlled study examined the effects of giving 500 mg oral DMAE dosages to children with hyperactivity. While these children were not diagnosed with ADHD at the time, it is likely that they would qualify under modern diagnosing guidelines.
The children were given 300 mg of this product in the morning and 200 mg at lunchtime and were observed for twelve weeks. Those given the treatment experienced greater behavioural improvements compared to those given the placebo.
Despite these positive results, two reviews of other clinical studies published in the 1970s found inconclusive results when giving DMAE to children with ADHD. Following this, there has been little further research into the effects of this supplement.
This is in part due to the fact that DMAE is no longer being sold as a prescription medication. When the costs of additional research became too high, its development was abandoned by Riker Laboratories.
Furthermore, because this compound is found naturally in fish, it would have proved difficult to patent in many markets around the world. As a result, it is still available today as a nutritional supplement, but has not been approved by the FDA for use in the treatment of ADHD, learning disabilities, behavioral problems or any other medical conditions.
DMAE Dosage
DMAE is used for a wide variety of purposes and in many different contexts. This also means that there will be a wide range of doses to consider. Proper dosage is dependent on many different factors, and it is always recommended that you speak with your doctor before beginning any new supplements.
For most people, this means starting off with a dose of around 150 mg per day. Of course, doses as high as 750 mg (and even more in some situations) have been used based on the desired effects and outcome.
In general, you will want to begin with the lowest effective dose. In most cases this will mean around the aforementioned 150 mg or so. Only increase this dose once you are sure about how it effects your body chemistry.
DMAE Side Effects
DMAE has been rated by the Natural Medicines database as Possibly Safe when orally and in reasonable doses. There are some contraindications, however.
People who have bipolar forms of depression, epilepsy, Parkinson’s disease, and/or seizure disorders would not be good candidates for DMAE use. These individuals may see a worsening of side effects if they take this product.
Additionally, women who are pregnant or nursing should not use this supplement unless given approval by their doctor or another qualified medical professional.
DMAE may be teratogenic (potential to cause birth defects) when taken by women who have recently conceived. Ethanolamines may compete with choline for uptake and utilization in cells, potentially causing negative effects during fetal development.
The side effects that have been typically associated with DMAE include gastrointestinal distress, high blood pressure, irritability, confusion, drowsiness, moderate depression, and sometimes a strange body odor. The smell is usually similar to decaying fish and is a by-product of the choline break down.
This supplement may interfere with the effects of certain medications. It should not be taken by anyone using cholinergic or anti-cholinergic medications, unless directed to do so by your physician.
DMAE may also interact with Acetylcholinesterase (AChE) Inhibitors, which are medications that block the acetylcholinesterase enzyme from breaking down the neurotransmitter acetylcholine following its release from neurons.
Theoretically, the combination of this supplement with an AChE inhibitor could cause excessively high levels of acetylcholine to accumulnate in the brain, resulting in side effects. Use caution if you are taking medications the medications Aricept, Cognex, Exelon, Reminyl or Razadyne. Also consult with a doctor before combining DMAE with the supplements Galantamine or Huperzine A.
DMAE Review
DMAE is a nootropic supplement that is commonly used to promote brain function and memory. According to anecdotal user reviews, it is noted for increasing energy, attentiveness, concentration, and improving mood. As a precursor to Acetylcholine and a source of choline, it can contribute to increased synaptic plasticity and better brain cell maintenance.
There have been some clinical research studies on the effects of this dietary supplement, but more research is needed to evaluate its effectiveness for therapeutic use. Most of the evidence of the purported benefits currently comes from user testimonials and experience logs.
DMAE supplements may be effective for supporting memory function, especially when taken in conjunction with Piracetam or Noopept. If you are looking for something stronger with a more potent boost to focus and motivation, consider trying Centrophenoxine which is an enhanced version of DMAE.
- Malanga G, Aguiar MB, Martinez HD, Puntarulo S. New insights on dimethylaminoethanol (DMAE) features as a free radical scavenger. Drug Metab Lett. 2012
- Liu S, Chen Z, Cai X, Sun Y, Zhao C, Liu F, Liu D. Effects of dimethylaminoethanol and compound amino acid on D-galactose induced skin aging model of rat. ScientificWorldJournal. 2014
- Tadini KA, Campos PM. In vivo skin effects of a dimethylaminoethanol (DMAE) based formulation. Pharmazie. 2009
- Blin O, Audebert C, Pitel S, Kaladjian A, Casse-Perrot C, Zaim M, Micallef J, Tisne-Versailles J, Sokoloff P, Chopin P, Marien M. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology (Berl). 2009
- Dimpfel W, Wedekind W, Keplinger I. Efficacy of dimethylaminoethanol (DMAE) containing vitamin-mineral drug combination on EEG patterns in the presence of different emotional states. Eur J Med Res. 2003
- Sergio W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid dreams. Med Hypotheses. 1988
- Goldenberg MM, Burns RH. The influence of DMAE and its parent substance hemicholinium on intestinal contractions in the dog. Eur J Pharmacol. 1972
- Danysz A, Smieta?ski J, Panek W. The influence of 2-dimethylaminethanol (DMAE) on the mental and physical efficiency in man. Act Nerv Super (Praha). 1967
- BOSTOCK J, SHACKLETON M. The use of DMAE (Deaner") in behaviour states." Med J Aust. 1962
- Laborit H, Weber B, Baron C, Delbarre B, Pavlovichova H. [2-Dimethylaminoethyl-4-methyl-5-ethyl-3-pyridazone (DMAE MEP or Ag 148) cardiovascular analeptic, vasodilator and hypertensive agent]. Agressologie. 1965
- Goldenberg MM. Differential antagonism between DMAE (a hemicholinium derivative) and atropine on contractile responses of the rat ileum. Arch Int Pharmacodyn Ther. 1971
- Chiou CY, Long JP. Effects of alpha,alpha'-bis-(dimethylammoniumacetaldehyde diethylacetal)-p,p'-diacetylbiphenyl bromide (DMAE) on neuromuscular transmission. J Pharmacol Exp Ther. 1969
- Pugliese L, Papeschi R. [A study of 2-dimethylaminoethanol (DMAE) in various forms of psychoneurosis]. Riv Neurobiol. 1966
- ISAKSSON A, MORSING C. [DMAE--a new central-stimulating psychopharmacon? Clinical trials using the doubleblind method]. Sven Lakartidn. 1963
- KLEINSORGE H, RUHE R. [Studies on the effectiveness of dimethylaminoethanol (DMAE) with and without vitamin supplement in the treatment of geriatric diseases]. Med Welt. 1961
- Grossman R. The role of dimethylaminoethanol in cosmetic dermatology. Am J Clin Dermatol. 2005
- Davis KL, Hollister LE, Vento AL, Beilstein BA, Rosekind GR. Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia. Psychopharmacology (Berl). 1979
- Noskov DS, Poro?kov VV, Shikh EV, Iasnetsov VV. [Deanol aceglumate (nooclerin): clinical/pharmacological aspects and relevance in clinical practice]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013
- Blinov DS, Gogina ED, Krupnova TS, Balashov VP, blinova EV, Sadovnikov VN, Lebedev AB, Nikitina OI. [Hepatoprotective effect of deanol aceglumate on experimental stress-induced gastropathy and diabetes mellitus]. Eksp Klin Farmakol. 2012
- Russell RW, Jenden DJ. Behavioral effects of deanol, of hemicholinium and of their interaction. Pharmacol Biochem Behav. 1981
- Jope RS, Jenden DJ. Dimethylaminoethanol (deanol) metabolism in rat brain and its effect on acetylcholine synthesis. J Pharmacol Exp Ther. 1979
- Millington WR, McCall AL, Wurtman RJ. Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline. Ann Neurol. 1978
- Stafford JR, Fann WE. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia. Dis Nerv Syst. 1977
- Zahniser NR, Chou D, Hanin I. Is 2-dimethylaminoethanol (deanol) indeed a precursor of brain acetylcholine? A gas chromatographic evaluation. J Pharmacol Exp Ther. 1977
- Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther. 1975
- Haubrich DR, Gerber NH, Pflueger AB. Deanol affects choline metabolism in peripheral tissues of mice. J Neurochem. 1981
- de Montigny C, Chouinard G, Annable L. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study. Psychopharmacology (Berl). 1979
- Klawans HL, Topel JL, Bergen D. Deanol in the treatment of levodopa-induced dyskinesias. Neurology. 1975
- George J, Pridmore S, Aldous D. Double blind controlled trial of deanol in tardive dyskinesia. Aust N Z J Psychiatry. 1981
- Jus A, Villeneuve A, Gautier J, Jus K, Villeneuve C, Pires P, Villeneuve R. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study. Neuropsychobiology. 1978
- Lewis JA, Lewis BS. Deanol in minimal brain dysfunction. Dis Nerv Syst. 1977
- Lindeboom SF, Lakke JP. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias. Acta Neurol Scand. 1978
- Pinta ER. Deanol in Gilles de la Tourette Syndrome: a preliminary investigation. Dis Nerv Syst. 1977
- Kocher R, Hobi V, Linder M, Studer K. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia]. Schweiz Arch Neurol Neurochir Psychiatr. 1980
- Marsh GR, Linnoila M. The effects of deanol on cognitive performance and electrophysiology in elderly humans. Psychopharmacology (Berl). 1979
- Ferris SH, Sathananthan G, Gershon S, Clark C. Senile dementia: treatment with deanol. J Am Geriatr Soc. 1977
- Casey DE. Mood alterations during deanol therapy. Psychopharmacology (Berl). 1979
- Kostopoulos GK, Phillis JW. The effects of dimethylaminoethanol (deanol) on cerebral cortical neurons. Psychopharmacol Commun. 1975
- Re' O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Res Clin Exp. 1974
- Amsterdam JD, Dubin W. Huntington's Chorea and dimethylaminoethanol (deanol). J Clin Psychiatry. 1978
- TAPIA F. MEDICATION OF BRAIN-DAMAGED" CHILDREN: A DOUBLE BLIND STUDY WITH DEANOL." Dis Nerv Syst. 1965
- Caffarra P, Cattelani R, Mazzucchi A, Moretti G, Parma M. [The effect of Deanol on amnesic disorders. A preliminary trial (author's transl)]. Ateneo Parmense Acta Biomed. 1980
- Ceder G, Dahlberg L, Schuberth J. Effects of 2-dimethylaminoethanol (Deanol) on the metabolism of choline in plasma. J Neurochem. 1978
- Casey DE. Deanol in the management of involuntary movement disorders: a review. Dis Nerv Syst. 1977
- Oettinger L Jr. Pediatric psychopharmacology. A review with special reference to deanol. Dis Nerv Syst. 1977
- Weiner WJ, Kanapa DJ, Klawans HL. The effect of dimethylaminoethanol (deanol) on amphetamine-induced stereotyped behavior (AISB). Life Sci. 1976
- Coleman N, Dexheimer P, DiMascio A, Redman W, Finnerty R. Deanol in the treatment of hyperkinetic children. Psychosomatics. 1976
- Haubrich DR, Wang PF, Clody DE, Wedeking PW. Increase in rat brain acetylcholine induced by choline or deanol. Life Sci. 1975
- Coats ME. Meige's disease and a positive treatment response with deanol. Mil Med. 1985
- Branyon DW, McDanal CE Jr. Deanol treatment of tics in a 10-year-old girl. Am J Psychiatry. 1983
- Finney JW, Christophersen ER, Ziegler DK. Deanol and Tourette syndrome. Lancet. 1981
- Haubrich DR, Risley EA, Williams M. Effects of deanol, choline and its metabolites on binding of [3H]quinuclidinyl benzilate to rat brain membranes. Biochem Pharmacol. 1979
- Goldberg AM. Is deanol a precursor of acetylcholine? Dis Nerv Syst. 1977
- Dhawan KN, Sinha JN, Gupta GP. A study of the central vasomotor effects of 2-dimethyl aminoethanol (Deanol). Jpn J Pharmacol. 1967
- Raab E, Carranza J, Heaney J, Rickels K. Deanol (paxanol) in anxiety. (A contribution to the methodology of cross-over studies). Dis Nerv Syst. 1966
- Malitz S, Wilkens B, Higgins JC, Kanzler M. A pilot evaluation of deanol in the treat- ment of anxiety. Curr Ther Res Clin Exp. 1967
- Ansell GB, Spanner SG. [Dimethylaminoethanol metabolism in rat brain]. Zh Evol Biokhim Fiziol. 1979
- Ceder G, Schuberth J. 2-Dimethylaminoethanol (Deaner) in body fluids. J Pharm Pharmacol. 1977
- JACOBS J. A CONTROLLED TRIAL OF DEANER AND A PLACEBO IN MENTALLY DEFECTIVE CHILDREN. Br J Clin Pract. 1965
- HAUSCHILD F, SEIDEL K, WIEZOREK WD, GEBHARD J. [DIMETHYLAMINOETHANOL IN THE THERAPY OF SCHIZOPHRINIC AND OLIGOPHRENIC CONDITIONS]. Dtsch Gesundheitsw. 1964
- LABRIOLA RS. [50 CHILD BEHAVIOR DISORDERS TREATED WITH 2-DIMETHYLAMINOETHANOL]. Dia Med. 1964
- PFEIFFER CC, GOLDSTEIN L, MUNOZ C, MURPHREE HB, JENNEY EH. Quantitative comparisons of the electroencephalographic stimulant effects of deanol, choline, and amphetamine. Clin Pharmacol Ther. 1963
- FLEMING JW, ORLANDO R. Effect of deanol on attention in the mentally retarded: a reaction time method. J New Drugs. 1962
- HUDDLESTON W, STAIGER RC, FRYE R, MUSGRAVE RS, STRITCH T. Deanol as aid in overcoming reading retardation. Clin Med (Northfield). 1961
- FIELDS EM. The effects of Deanol in children with organic and functional behavior disorders. N Y State J Med. 1961
- PEPEU G, FREEDMAN DX, GIARMAN NJ. Biochemical and pharmacological studies of dimethylaminoethanol (deanol). J Pharmacol Exp Ther. 1960
- MURPHREE HB Jr, PFEIFFER CC, BACKERMAN IA. The stimulant effect of 2-dimethylaminoethanol (deanol) in human volunteer subjects. Clin Pharmacol Ther. 1960
- DOMINIAN J. Deanol in depression. A controlled trial. J Ment Sci. 1960
- PORTNOW SL, ARDIS MB, LUBACH JE. The effect of deanol on the activity of chronic schizophrenic patients. Am J Psychiatry. 1960
- MORIARTY JD, MEBANE JC. Clinical experiences with deanol (deaner): a different type of psychic energizer"." J Neuropsychiatr. 1959
- PENNINGTON VM. Clinical results with the use of deanol (deaner) in schizophrenia. Am J Psychiatry. 1959
- MORIARTY JD, MEBANE JC. Clinical uses of deanol (deaner): a new type of psychotropic drug. Am J Psychiatry. 1959
- MELLER RL. Treatment of mild depression with deanol para-acetamidobenzoate. J Lancet. 1959
- OETTINGER L Jr. The use of deanol in the treatment of disorders of behavior in children. J Pediatr. 1958
- PFEIFFER CC. Deanol: a biochemical stimulant. Mod Hosp. 1958
- LEMERE F, LASATER JH. Deanol (deaner) a new cerebral stimulant for the treatment of neurasthenia and mild depression: a preliminary report. Am J Psychiatry. 1958
- REBOLLO MA, CASAS M. [Use of Deaner" (deanol) in children with clinical and/or electroencephalographic epilepsy]." Arch Pediatr Urug. 1961
- MEBANE JC. Use of deanol with disturbed juvenile offenders. Dis Nerv Syst. 1960
- SETTEL E. Stimulant therapy with deanol in depression, migraine, and tension headaches. J Am Geriatr Soc. 1959
- TOBIAS M. The disturbed child-a concept: usefulness of deanol in management. Am Pract Dig Treat. 1959
- BARSA JA, SAUNDERS JC. Deanol (deaner) in the treatment of schizophrenia. Am J Psychiatry. 1959
Article last updated on: March 13th, 2018 by Nootriment
3 Comments
Buenas noche. quisiera saber si lo puede tomar una persona que tome anticonvulsivo, valpron y keppa 1500mg diarios..
In your “cons” column, you say that DMAE doesn’t cross the blood brain barrier well. Elsewhere, you say it does. I’m confused.
Yea I found that funny too KMC. Contradicted themselves in the same article.